Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI.

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Industry experts see this breakthrough as a potential game-changer in biomedical research and development. Google DeepMind spinoff Biotech moves AI-designed drug to human trials 中文網 ...

A New Era of Research with Health Studio Clinical trials are the backbone of medical advancement but they’ve historically ...